BofA/Merrill Lynch Upgrades ResMed (RMD) to Buy
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
BofA/Merrill Lynch upgraded ResMed (NYSE: RMD) from Neutral to Buy.
Shares of ResMed closed at $64.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WestRock (WRK) to Acquire Multi Packaging Solutions (MPSX) for $18 per share
- Definitive Agreement Reached for WestRock to Acquire Multi Packaging Solutions for $18.00 per share
- Visible Alpha Acquires ONEaccess to Help Investment Professionals Uncover Unique Insights from Sell-Side Content
Create E-mail Alert Related CategoriesUpgrades
Related EntitiesMerrill Lynch, Bank of America
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!